一文掌握 | 手足综合征如何应对( 二 )

? 本文仅供医疗卫生等专业人士参考
策划：GoEun ，梅浙投稿及合作：yinqihang@dxy.cn
本文插图
[1] 孙勇生, 谢长生. 抗肿瘤药物引致手足综合征的中西医诊疗进展 [J]. 肿瘤学杂志,2018,24(03):271-277.
[2]Duggan S.T.,Ferrandina G.,Lorusso D.,et al.Pegylated liposomal doxorubicin: A review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposis sarcoma[J].Drugs: International Journal of Current Therapeutics & Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs & Drug Therapy, and Drug Literature Abstracts,2011,71(18).
[3] 吴启权, 吴剑秋, 汤唯艳, 周建梅, 潘奕彤, 汤依群. 多柔比星脂质体对 DLBCL 化疗致手足综合征的危险因素分析及防治措施 [J]. 药学与临床研究,2017,25(03):217-220.
[4]O'Brien ME,Ackland SP,Alland L,et al.Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX(TM)/Doxil((R))) versus conventional doxorubicin for first-line treatment of metastatic breast cancer.[J].Annals of oncology: official journal of the European Society for Medical Oncology,2004,15(3).
【一文掌握 | 手足综合征如何应对】[5] 蒋言涛. 化疗致手足综合征的防治进展研究 [J]. 医师在线, 2019, (3)